Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$43,356,101
+$43,356,101 QoQ
Shares Held
283,837
Ownership
0.015%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Mar 31, 2026CallValue
$6,690,450
CallShares
43,800
PutValue
$1,283,100
PutShares
8,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $795,359,411 across 11 Drug Manufacturers - General names. NVS ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,233,965 | $243,362,577 | |
| 2 | BIIB |
Biogen Inc.
|
809,617 | $148,427,084 | |
| 3 | PFE |
Pfizer Inc
|
4,365,063 | $122,570,969 | |
| 4 | MRK |
Merck & Co., Inc.
|
921,077 | $110,796,352 | |
| 5 | LLY |
ELI LILLY & Co
|
95,766 | $88,082,693 | |
| 6 | NVS |
Novartis AG
This page
|
283,837 | $43,356,101 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
531,198 | $32,217,158 | |
| 8 | AMRN |
Amarin Corp Plc\Uk
|
240,761 | $3,481,404 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,356,101 | 283,837 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $6,690,450 | 43,800 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,283,100 | 8,400 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $5,363,143 | 38,900 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $220,592 | 1,600 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $205,184 | 1,600 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $3,949,792 | 30,800 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $90,358,893 | 746,706 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $3,727,108 | 30,800 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $120,663,165 | 1,082,375 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $14,681,916 | 131,700 | Call | Defined | 2025-07-21 | |
| 2024-12-31 | $2,997,148 | 30,800 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $3,531,114 | 30,700 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $11,502,000 | 100,000 | Put | Defined | 2024-11-14 | |
| 2023-12-31 | $1,867,945 | 18,500 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $1,884,410 | 18,500 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $18,461,819 | 181,247 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $91,453,320 | 906,286 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $44,440,764 | 440,400 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $1,702,000 | 18,500 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $166,643,924 | 1,811,347 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $64,030,176 | 705,800 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $49,383,697 | 649,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,460,436 | 301,200 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $13,374,163 | 152,900 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $69,127,112 | 794,930 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||